Argenta Discovery Ltd.

Argenta Discovery is a new UK-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series. Argenta comprises a mix of scientists skilled in computer-aided drug design, medicinal and combinatorial chemistry, and assay development and automated biochemical screening, forming one team for the in vitro optimisation of candidates. Argenta Discovery is also actively working on its own projects for which patentable lead series will be available for sale or license. Argenta has a contract with Imperial College of Science, Technology and Medicine in London for First Right of Refusal for targets from several research groups.

Activity:

Product / Technology type(s) covered:

- Bio

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: